| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | RAD51 SYNRG PKP4 CNTRL GBP3 CTIF RYR3 BICD1 BCAP31 UPF2 NF2 GBP5 PDE8B TLR4 RAB40C RAB40B PATJ MAP2K1 | 1.01e-04 | 934 | 147 | 18 | GO:0048471 |
| Domain | ARM-type_fold | MON2 HIP1 PKP4 UBR4 RTTN CTIF RYR3 NCAPG SF3B1 UPF2 CEBPZ CTNND2 | 1.37e-05 | 339 | 145 | 12 | IPR016024 |
| Domain | Ryanodine_rcpt | 1.79e-04 | 3 | 145 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 1.79e-04 | 3 | 145 | 2 | IPR009460 | |
| Domain | RyR | 1.79e-04 | 3 | 145 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 1.79e-04 | 3 | 145 | 2 | PF06459 | |
| Domain | Ryan_recept | 1.79e-04 | 3 | 145 | 2 | IPR013333 | |
| Domain | RIH_assoc-dom | 8.80e-04 | 6 | 145 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 8.80e-04 | 6 | 145 | 2 | PF08709 | |
| Domain | RIH_assoc | 8.80e-04 | 6 | 145 | 2 | PF08454 | |
| Domain | RIH_dom | 8.80e-04 | 6 | 145 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 8.80e-04 | 6 | 145 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 8.80e-04 | 6 | 145 | 2 | IPR015925 | |
| Domain | - | 8.80e-04 | 6 | 145 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 8.80e-04 | 6 | 145 | 2 | PF01365 | |
| Domain | THIOREDOXIN_1 | 9.30e-04 | 25 | 145 | 3 | PS00194 | |
| Domain | Plakophilin/d_Catenin | 1.23e-03 | 7 | 145 | 2 | IPR028435 | |
| Domain | Chaprnin_Cpn60 | 2.08e-03 | 9 | 145 | 2 | IPR001844 | |
| Domain | Chaperonin_TCP-1_CS | 2.08e-03 | 9 | 145 | 2 | IPR002194 | |
| Domain | P-loop_NTPase | RAD51 MYH10 CENPE LONP2 MTHFD1L GBP3 KIF3A ADSS2 RUVBL1 GBP5 TK1 RAB40C ABCC12 RAB40B RAD54L | 2.49e-03 | 848 | 145 | 15 | IPR027417 |
| Domain | MIR | 2.59e-03 | 10 | 145 | 2 | PF02815 | |
| Domain | MIF4G | 2.59e-03 | 10 | 145 | 2 | SM00543 | |
| Domain | MIR_motif | 2.59e-03 | 10 | 145 | 2 | IPR016093 | |
| Domain | MIF4G | 2.59e-03 | 10 | 145 | 2 | PF02854 | |
| Domain | TCP1_1 | 2.59e-03 | 10 | 145 | 2 | PS00750 | |
| Domain | TCP1_2 | 2.59e-03 | 10 | 145 | 2 | PS00751 | |
| Domain | TCP1_3 | 2.59e-03 | 10 | 145 | 2 | PS00995 | |
| Domain | GBP_C | 2.59e-03 | 10 | 145 | 2 | PF02841 | |
| Domain | MIF4G-like_typ-3 | 2.59e-03 | 10 | 145 | 2 | IPR003890 | |
| Domain | MIR | 2.59e-03 | 10 | 145 | 2 | PS50919 | |
| Domain | MIR | 2.59e-03 | 10 | 145 | 2 | SM00472 | |
| Domain | Chaperone_TCP-1 | 2.59e-03 | 10 | 145 | 2 | IPR017998 | |
| Domain | G_GB1_RHD3_dom | 3.14e-03 | 11 | 145 | 2 | IPR030386 | |
| Domain | - | 3.14e-03 | 11 | 145 | 2 | 3.30.260.10 | |
| Domain | TCP-1-like_intermed | 3.14e-03 | 11 | 145 | 2 | IPR027410 | |
| Domain | Guanylate-bd_N | 3.14e-03 | 11 | 145 | 2 | IPR015894 | |
| Domain | Guanylate-bd_C | 3.14e-03 | 11 | 145 | 2 | IPR003191 | |
| Domain | GBP | 3.14e-03 | 11 | 145 | 2 | PF02263 | |
| Domain | G_GB1_RHD3 | 3.14e-03 | 11 | 145 | 2 | PS51715 | |
| Domain | Thioredoxin_domain | 3.94e-03 | 41 | 145 | 3 | IPR013766 | |
| Domain | THIOREDOXIN_2 | 4.51e-03 | 43 | 145 | 3 | PS51352 | |
| Domain | - | 4.53e-03 | 333 | 145 | 8 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 4.70e-03 | 335 | 145 | 8 | IPR015943 | |
| Domain | GROEL-like_equatorial | 5.12e-03 | 14 | 145 | 2 | IPR027413 | |
| Domain | - | 5.12e-03 | 14 | 145 | 2 | 1.10.560.10 | |
| Domain | - | 5.88e-03 | 15 | 145 | 2 | 1.25.40.180 | |
| Domain | GroEL-like_apical_dom | 5.88e-03 | 15 | 145 | 2 | IPR027409 | |
| Domain | Cpn60/TCP-1 | 5.88e-03 | 15 | 145 | 2 | IPR002423 | |
| Domain | Cpn60_TCP1 | 5.88e-03 | 15 | 145 | 2 | PF00118 | |
| Domain | - | 5.88e-03 | 15 | 145 | 2 | 3.50.7.10 | |
| Domain | MIF4-like | 5.88e-03 | 15 | 145 | 2 | IPR016021 | |
| Domain | MAM_1 | 6.69e-03 | 16 | 145 | 2 | PS00740 | |
| Domain | MAM | 7.54e-03 | 17 | 145 | 2 | SM00137 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | FLNB MYH10 TBRG4 ERCC5 EMC1 CCT3 LONP2 GLRX3 MTHFD1L UBR4 DIDO1 PATL1 TFG GSR PWP1 LUC7L NCAPG SF3B1 RUVBL1 DCD TSR1 CEBPZ TK1 DLAT SCAF11 MTCL1 TRMT1L DYNC1I2 LRRFIP1 | 1.73e-12 | 1415 | 148 | 29 | 28515276 |
| Pubmed | FLNB MYH10 CIB2 ERCC5 CCT3 PCDHGA7 CFL2 PPFIA2 CNTRL UBR4 RBM42 RYR2 GSR HNRNPCL3 PDIA4 BCAP31 KRT76 SF3B1 CEBPZ SCN4A NFXL1 DLAT ATP2B2 MED13 DYNC1I2 RAI1 ZNF292 BAHCC1 | 1.57e-11 | 1442 | 148 | 28 | 35575683 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLNB VRK1 MYH10 TBRG4 EMC1 CCT3 MTHFD1L UBR4 ETFB TFG GSR PDIA4 PWP1 LIG3 BCAP31 NCAPG SF3B1 STXBP3 ADSS2 RUVBL1 DCD TSR1 CEBPZ DLAT FGD5 TP53 CA2 | 6.63e-11 | 1425 | 148 | 27 | 30948266 |
| Pubmed | RAD51 MYH10 CCT3 PKP4 PATL1 TUBGCP4 CIT KIF3A LUC7L LIG3 BCAP31 SF3B1 ADSS2 RUVBL1 RNH1 NF2 TSR1 CEBPZ DLAT OXSR1 TRMT1L DOT1L PATJ MAP2K1 MED13 | 1.15e-10 | 1247 | 148 | 25 | 27684187 | |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | CAAP1 VRK1 UBE2Q1 CCT3 PKP4 RBM42 DAPK3 TFG COPS2 NXN CLCC1 PWP1 RUVBL1 RNH1 ZSCAN21 SNX6 OXSR1 PLEKHO1 TP53 | 1.92e-10 | 704 | 148 | 19 | 32994395 |
| Pubmed | FLNB MYH10 CCT3 MTHFD1L UBR4 ETFB RBM28 RB1CC1 TFG SF3B1 RUVBL1 RNH1 DCD DLAT SCAF11 TP53 CA2 | 2.45e-10 | 551 | 148 | 17 | 34728620 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | CAAP1 VRK1 MYH10 TBRG4 CCT3 MTHFD1L UBR4 ETFB DIDO1 PATL1 RBM28 PWP1 LUC7L NCAPG SF3B1 RUVBL1 RNH1 UPF2 TSR1 CEBPZ TK1 OXSR1 TRMT1L MAP2K1 CA2 | 3.63e-10 | 1318 | 148 | 25 | 30463901 |
| Pubmed | EMC1 PDK3 MTHFD1L CAMLG PKP4 UBR4 ETFB BBS2 RBM28 RB1CC1 CLCC1 GSR PDIA4 NBAS BCAP31 NCAPG SF3B1 STXBP3 NF2 SNX6 WDR11 TSR1 CEBPZ NFXL1 DLAT MAP2K1 | 8.66e-10 | 1487 | 148 | 26 | 33957083 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | RAD51 MYH10 TBRG4 EMC1 GLRX3 MTHFD1L UBR4 BCAS1 RB1CC1 COPS2 NXN QRICH2 PDIA4 LUC7L LIG3 FBLN1 NCAPG SF3B1 RUVBL1 DCD TSR1 OXSR1 ELL DYNC1I2 | 1.14e-09 | 1284 | 148 | 24 | 17353931 |
| Pubmed | MON2 FLNB HIP1 MYH10 TBRG4 EMC1 CCT3 GLRX3 MTHFD1L CFL2 UBR4 RBM28 TUBGCP4 COPS2 CLCC1 NBAS LUC7L LIG3 NCAPG SF3B1 ADSS2 RNH1 CEBPZ TRMT1L LRRFIP1 | 2.21e-09 | 1440 | 148 | 25 | 30833792 | |
| Pubmed | FLNB MYH10 CCT3 MTHFD1L UBR4 DIDO1 RBM28 PDIA4 PWP1 SF3B1 RNH1 TSR1 CEBPZ DLAT SCAF11 TP53 RAI1 | 3.17e-09 | 653 | 148 | 17 | 22586326 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNB MYH10 CCT3 MTHFD1L PKP4 UBR4 RBM28 LIG3 NCAPG SF3B1 ADSS2 RUVBL1 RNH1 UPF2 WDR11 DCD CEBPZ TK1 SBDS NFXL1 CCT6B DLAT PRR14L DYNC1I2 | 3.18e-09 | 1353 | 148 | 24 | 29467282 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | FLNB VRK1 HIP1 MYH10 CCT3 MTHFD1L UBR4 SQLE TFG COPS2 CLCC1 PDIA4 LUC7L BCAP31 NCAPG SF3B1 ADSS2 RUVBL1 SNX6 DCD TK1 OXSR1 DYNC1I2 LRRFIP1 | 3.88e-09 | 1367 | 148 | 24 | 32687490 |
| Pubmed | MON2 CENPE CAMLG PATL1 RBM28 TFG PRPF18 CLCC1 PDIA4 NBAS STXBP3 RNH1 CEBPZ TK1 NFXL1 PRR14L PATJ | 1.73e-08 | 733 | 148 | 17 | 34672954 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | FLNB MYH10 CCT3 CFL2 PKP4 DIDO1 DAPK3 RBM28 CIT PWP1 SF3B1 RUVBL1 RNH1 UPF2 WDR11 DCD TSR1 CEBPZ SCAF11 TRMT1L PATJ LRRFIP1 | 1.97e-08 | 1257 | 148 | 22 | 36526897 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | FLNB MYH10 CCT3 CFL2 ETFB RBM28 CIT PDIA4 LIG3 BCAP31 NCAPG SF3B1 RUVBL1 UPF2 SNX6 SBDS DYNC1I2 LRRFIP1 | 2.43e-08 | 847 | 148 | 18 | 35235311 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | SYNRG MYH10 CENPE MTHFD1L PKP4 CNTRL CTIF PATL1 CLCC1 BICD1 STXBP3 RUVBL1 WDR11 TSR1 CCT6B ELL DYNC1I2 TP53 | 2.70e-08 | 853 | 148 | 18 | 28718761 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | FLNB MYH10 CCT3 GLRX3 CFL2 UBR4 TFG COPS2 GSR PDIA4 LIG3 SF3B1 RUVBL1 SNX6 TSR1 DLAT TRMT1L PATJ DYNC1I2 TP53 | 1.01e-07 | 1149 | 148 | 20 | 35446349 |
| Pubmed | EMC1 LONP2 PKP4 DIDO1 PATL1 TUBGCP4 HNRNPCL3 PWP1 LIG3 UPF2 WDR11 TSR1 NFXL1 HNRNPCL4 PATJ | 1.35e-07 | 650 | 148 | 15 | 38777146 | |
| Pubmed | FLNB VRK1 HIP1 MYH10 CFL2 DAPK3 CIT PWP1 LIG3 SF3B1 RUVBL1 RNH1 NF2 TP53 LRRFIP1 | 1.64e-07 | 660 | 148 | 15 | 32780723 | |
| Pubmed | FLNB MYH10 CCT3 SYT3 CFL2 PPFIA2 PKP4 ETFB DAPK3 BCAS1 CIT KIF3A HNRNPCL3 KRT76 SF3B1 UPF2 DLAT CTNND2 MAP2K1 ATP2B2 CA2 LRRFIP1 | 1.88e-07 | 1431 | 148 | 22 | 37142655 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | FLNB CCT3 UBR4 DIDO1 NCAPG SF3B1 RUVBL1 TSR1 TK1 SCAF11 TRMT1L | 2.03e-07 | 332 | 148 | 11 | 32786267 |
| Pubmed | RAD51 MON2 SEMA4B VRK1 MYH10 UBR4 SQLE PATL1 MAPKAPK5 CLCC1 GSR NBAS RNH1 UPF2 NF2 SBDS DLAT MED13 ELL RAD54L ZNF292 | 2.29e-07 | 1327 | 148 | 21 | 32694731 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RAD51 MON2 SYNRG SEMA4B HIP1 MTHFD1L UBR4 RTTN MAPKAPK5 CIT KMT2D NF2 TMCC2 DOT1L SNAPC4 MED13 ELL RAI1 BAHCC1 | 2.62e-07 | 1105 | 148 | 19 | 35748872 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | FLNB MYH10 MTHFD1L UBR4 HNRNPCL3 PDIA4 KRT76 NCAPG SF3B1 DYNC1I2 CA2 | 2.89e-07 | 344 | 148 | 11 | 30333137 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FLNB MYH10 ATXN7L1 PPFIA2 EVC CTIF PATL1 NXN CLCC1 BICD1 LUC7L NF2 WDR11 GCC2 TBCK WDR45B SCAF11 RAB40B OXSR1 PATJ TET3 RAI1 | 3.68e-07 | 1489 | 148 | 22 | 28611215 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | VRK1 EMC1 CCT3 MTHFD1L UBR4 COPS2 NBAS NCAPG RUVBL1 RNH1 UPF2 CEBPZ TK1 OXSR1 DYNC1I2 | 3.71e-07 | 704 | 148 | 15 | 29955894 |
| Pubmed | 3.86e-07 | 281 | 148 | 10 | 26725010 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FLNB MYH10 CCT3 GLRX3 CNTRL UBR4 GBP3 TFG PDIA4 NBAS BCAP31 STXBP3 ADSS2 RUVBL1 DCD CA2 | 3.87e-07 | 807 | 148 | 16 | 30575818 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MYH10 TBRG4 EMC1 CCT3 CENPE PDK3 MTHFD1L CFL2 CAMLG UBR4 ETFB DAPK3 RBM28 CLCC1 PDIA4 NBAS LUC7L BCAP31 UPF2 SNX6 ALDH1L2 DLAT | 3.98e-07 | 1496 | 148 | 22 | 32877691 |
| Pubmed | MON2 SYNRG FLNB MYH10 EMC1 TSPOAP1 PDK3 PPFIA2 CAMLG UBR4 ETFB CIT RYR2 SF3B1 RUVBL1 TMCC2 DLAT CTNND2 LRRFIP1 | 4.14e-07 | 1139 | 148 | 19 | 36417873 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | RAD51 RBM28 LUC7L LIG3 NCAPG TSR1 CEBPZ SCAF11 TRMT1L MAP2K1 TP53 | 5.94e-07 | 370 | 148 | 11 | 22922362 |
| Pubmed | CENPE LONP2 MTHFD1L CAMLG CNTRL UBR4 TUBGCP4 CIT CLCC1 NBAS BCAP31 NCAPG RASAL3 NF2 GBP5 WDR11 GCC2 NFXL1 MED13 | 6.03e-07 | 1168 | 148 | 19 | 19946888 | |
| Pubmed | FLNB MYH10 CCT3 UBR4 BCAP31 NCAPG SF3B1 RUVBL1 RNH1 DCD DLAT TRMT1L DYNC1I2 TP53 | 6.55e-07 | 638 | 148 | 14 | 33239621 | |
| Pubmed | MYH10 CCT3 MTHFD1L RTTN ETFB RBM28 NCAPG SF3B1 RUVBL1 RNH1 DCD SBDS TRMT1L TP53 | 6.92e-07 | 641 | 148 | 14 | 36057605 | |
| Pubmed | 7.01e-07 | 300 | 148 | 10 | 28561026 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MON2 EMC1 CNTRL RBM28 TFG CIT CLCC1 PDIA4 STXBP3 RNH1 WDR11 CEBPZ GCC2 DYNC1I2 TP53 | 8.75e-07 | 754 | 148 | 15 | 33060197 |
| Pubmed | MON2 TBRG4 MTHFD1L RBM42 TUBGCP4 COPS2 CLCC1 BCAP31 NCAPG WDR11 DLAT DYNC1I2 TP53 | 8.98e-07 | 560 | 148 | 13 | 35241646 | |
| Pubmed | FLNB ERCC5 UBE2Q1 CAMLG CNTRL DIDO1 PATL1 RBM28 COPS2 PDIA4 NF2 ZSCAN21 TSR1 ALDH1L2 TLR4 NFXL1 DOT1L PATJ | 9.13e-07 | 1084 | 148 | 18 | 11544199 | |
| Pubmed | FLNB CCT3 RBM42 RBM28 PRPF18 PWP1 SF3B1 RUVBL1 UPF2 WDR11 TSR1 CEBPZ TK1 ALDH1L2 MTCL1 TRMT1L TP53 | 9.16e-07 | 971 | 148 | 17 | 33306668 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | FLNB MYH10 CCT3 PDIA4 BCAP31 SF3B1 DCD CEBPZ DLAT DYNC1I2 CA2 LRRFIP1 | 1.05e-06 | 477 | 148 | 12 | 31300519 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | FLNB PKP4 KIF3A LUC7L CABYR NCAPG ZSCAN21 SNX6 TSR1 CCT6B SCAF11 TRMT1L DYNC1I2 TP53 | 1.16e-06 | 670 | 148 | 14 | 22990118 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SYNRG CAAP1 ERCC5 PDPK1 DIDO1 PATL1 PWP1 KMT2D SF3B1 SCAF11 OXSR1 SNAPC4 MED13 DYNC1I2 LRRFIP1 | 1.21e-06 | 774 | 148 | 15 | 15302935 |
| Pubmed | FLNB HIP1 MYH10 CCT3 TFG SF3B1 RUVBL1 RNH1 DCD DLAT DYNC1I2 TP53 | 1.33e-06 | 488 | 148 | 12 | 31324722 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | FLNB MYH10 LONP2 MTHFD1L RBM42 COPS2 NXN KIF3A LUC7L RNH1 NF2 GCC2 ABCC12 MTCL1 ELL TP53 CA2 | 1.46e-06 | 1005 | 148 | 17 | 19615732 |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | HIP1 GLRX3 PDPK1 PKP4 UBR4 LENG1 TUBGCP4 MAPKAPK5 EGFL6 PDIA4 SF3B1 RUVBL1 CEBPZ TK1 CTNND2 SNAPC4 TP53 RAI1 | 1.52e-06 | 1124 | 148 | 18 | 21900206 |
| Pubmed | CAAP1 MYH10 ETFB RBM42 DIDO1 PATL1 RBM28 TFG PWP1 LUC7L SF3B1 RUVBL1 UPF2 DCD TSR1 CEBPZ DLAT SCAF11 TP53 LRRFIP1 | 1.60e-06 | 1371 | 148 | 20 | 36244648 | |
| Pubmed | VRK1 CCT3 GLRX3 UBR4 DIDO1 COPS2 LIG3 NCAPG SF3B1 ADSS2 RNH1 TSR1 SBDS OXSR1 TRMT1L MED13 TP53 | 1.65e-06 | 1014 | 148 | 17 | 32416067 | |
| Pubmed | BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer | 1.78e-06 | 21 | 148 | 4 | 20301425 | |
| Pubmed | MYH10 CCT3 UBR4 DIDO1 RBM28 LUC7L NCAPG SF3B1 RUVBL1 TSR1 NFXL1 SCAF11 MTCL1 | 1.96e-06 | 601 | 148 | 13 | 33658012 | |
| Pubmed | Evolutionarily conserved regulators of tau identify targets for new therapies. | EMC1 CCT3 CAMLG CLCC1 PDIA4 BCAP31 STXBP3 ADSS2 RUVBL1 SNX6 DCD NFXL1 | 2.36e-06 | 516 | 148 | 12 | 36610398 |
| Pubmed | MON2 MYH10 EMC1 CCT3 PKP4 DAPK3 RB1CC1 CLCC1 PDIA4 KMT2D NCAPG STXBP3 NF2 SNX6 WDR11 TSR1 CEBPZ | 2.60e-06 | 1049 | 148 | 17 | 27880917 | |
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 21242963 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | SYNRG CAAP1 PATL1 PDIA4 RUVBL1 UPF2 NF2 CEBPZ SBDS NFXL1 OXSR1 DYNC1I2 LRRFIP1 ZNF292 | 2.86e-06 | 724 | 148 | 14 | 36232890 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | FLNB CAAP1 MYH10 CCT3 RBM28 RB1CC1 HNRNPCL3 PDIA4 LUC7L SF3B1 NF2 DCD TSR1 CEBPZ HNRNPCL4 LRRFIP1 | 3.17e-06 | 949 | 148 | 16 | 36574265 |
| Pubmed | FLNB GLRX3 PDK3 MTHFD1L UBR4 PDIA4 NCAPG SF3B1 STXBP3 RNH1 SBDS CA2 | 3.35e-06 | 534 | 148 | 12 | 35032548 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CAAP1 VRK1 CFL2 DIDO1 RBM28 HNRNPCL3 LIG3 SF3B1 RUVBL1 ZSCAN21 DCD CEBPZ SCAF11 ELL TP53 RAI1 | 3.38e-06 | 954 | 148 | 16 | 36373674 |
| Pubmed | MYH10 PKP4 UBR4 LENG1 ETFB RBM28 COPS2 PWP1 TK1 SBDS SCAF11 TRMT1L TP53 | 3.50e-06 | 634 | 148 | 13 | 34591612 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RAD51 MON2 FLNB CCT3 GLRX3 UBR4 TFG COPS2 GSR PDIA4 NCAPG ADSS2 RUVBL1 RNH1 SNX6 TSR1 SBDS OXSR1 DYNC1I2 LRRFIP1 | 3.92e-06 | 1455 | 148 | 20 | 22863883 |
| Pubmed | 4.38e-06 | 26 | 148 | 4 | 20731661 | ||
| Pubmed | MYH10 EMC1 PATL1 RBM28 PDIA4 PWP1 LUC7L SF3B1 WDR11 DCD TSR1 OXSR1 TRMT1L | 4.82e-06 | 653 | 148 | 13 | 33742100 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CENPE PDK3 DIDO1 RBM28 PWP1 LIG3 RUVBL1 UPF2 TSR1 CEBPZ DLAT SCAF11 TRMT1L LRRFIP1 | 4.92e-06 | 759 | 148 | 14 | 35915203 |
| Pubmed | FLNB HIP1 CCT3 GLRX3 ETFB PDIA4 NCAPG SF3B1 ADSS2 RNH1 DLAT OXSR1 MAP2K1 DYNC1I2 ZNF292 | 5.59e-06 | 878 | 148 | 15 | 37223481 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | FLNB MYH10 CCT3 MTHFD1L UBR4 ETFB COPS2 HNRNPCL3 LUC7L RNH1 CCT6B DLAT MAP2K1 | 5.86e-06 | 665 | 148 | 13 | 30457570 |
| Pubmed | An integrated workflow for charting the human interaction proteome: insights into the PP2A system. | 6.10e-06 | 105 | 148 | 6 | 19156129 | |
| Pubmed | Citron Kinase Deficiency Leads to Chromosomal Instability and TP53-Sensitive Microcephaly. | 6.23e-06 | 9 | 148 | 3 | 28199840 | |
| Pubmed | FLNB MYH10 CCT3 MTHFD1L RBM28 TFG BCAP31 NCAPG STXBP3 RUVBL1 DLAT | 7.82e-06 | 484 | 148 | 11 | 31995728 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | MYH10 DIDO1 LUC7L LIG3 NCAPG RUVBL1 SCAF11 DYNC1I2 TP53 RAI1 | 7.91e-06 | 394 | 148 | 10 | 27248496 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | VRK1 UBE2Q1 CCT3 TUBGCP4 LUC7L NCAPG SF3B1 RUVBL1 MED12L OXSR1 MTCL1 TRMT1L | 7.98e-06 | 582 | 148 | 12 | 20467437 |
| Pubmed | 9.06e-06 | 31 | 148 | 4 | 20813000 | ||
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | FLNB MYH10 CCT3 TFG COPS2 PDIA4 ADSS2 RUVBL1 CA2 LRRFIP1 BAHCC1 | 9.64e-06 | 495 | 148 | 11 | 28581483 |
| Pubmed | MYH10 CCT3 KIF3A BCAP31 SF3B1 RUVBL1 RNH1 WDR11 DCD TSR1 DLAT DYNC1I2 TP53 LRRFIP1 | 1.01e-05 | 809 | 148 | 14 | 32129710 | |
| Pubmed | FLNB MYH10 EMC1 CCT3 MTHFD1L UBR4 DIDO1 RB1CC1 TFG GSR PDIA4 SF3B1 SNX6 TSR1 OXSR1 MTCL1 TRMT1L MAP2K1 | 1.09e-05 | 1297 | 148 | 18 | 33545068 | |
| Pubmed | 1.10e-05 | 68 | 148 | 5 | 20496165 | ||
| Pubmed | MYH10 CCT3 ATXN7L1 UBR4 DIDO1 PATL1 RBM28 CIT PDIA4 PWP1 LIG3 KMT2D BCAP31 ZSCAN21 DLAT SCAF11 TRMT1L DOT1L TP53 | 1.12e-05 | 1429 | 148 | 19 | 35140242 | |
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | RAD51 MON2 LONP2 GLRX3 NUP210L MTHFD1L ETFB NXN PDIA4 RPIA SNX6 WDR11 DCD DLAT WDR45B | 1.12e-05 | 931 | 148 | 15 | 27432908 |
| Pubmed | FLNB SEMA4B CAAP1 MYH10 EMC1 UBR4 CLCC1 PDIA4 LIG3 BCAP31 TP53 | 1.12e-05 | 503 | 148 | 11 | 36217030 | |
| Pubmed | Dlec1 is required for spermatogenesis and male fertility in mice. | 1.22e-05 | 11 | 148 | 3 | 33144677 | |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 1.38e-05 | 182 | 148 | 7 | 31067453 | |
| Pubmed | CCT3 MTHFD1L RBM28 LUC7L SF3B1 RUVBL1 NF2 TSR1 TK1 CCT6B TRMT1L PATJ | 1.38e-05 | 615 | 148 | 12 | 31048545 | |
| Pubmed | TBRG4 CCT3 MTHFD1L CAMLG PKP4 SQLE CLCC1 BICD1 PDIA4 BCAP31 STXBP3 WDR11 SBDS NFXL1 DLAT | 1.45e-05 | 952 | 148 | 15 | 38569033 | |
| Pubmed | ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection. | 1.49e-05 | 336 | 148 | 9 | 31253590 | |
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 29459437 | ||
| Pubmed | MYH10 CCT3 SYT3 CENPE PKP4 UBR4 DIDO1 DAPK3 CIT KIF3A SF3B1 MTCL1 CTNND2 RAI1 LRRFIP1 | 1.66e-05 | 963 | 148 | 15 | 28671696 | |
| Pubmed | Role of heteroduplex joints in the functional interactions between human Rad51 and wild-type p53. | 1.80e-05 | 2 | 148 | 2 | 11002423 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 32697937 | ||
| Pubmed | Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL. | 1.80e-05 | 2 | 148 | 2 | 12773566 | |
| Pubmed | Analysis of mouse Rad54 expression and its implications for homologous recombination. | 1.80e-05 | 2 | 148 | 2 | 12531026 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 38103365 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 9380510 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 15611070 | ||
| Pubmed | Mouse Rad54 affects DNA conformation and DNA-damage-induced Rad51 foci formation. | 1.80e-05 | 2 | 148 | 2 | 10209103 | |
| Pubmed | p53 downregulates its activating vaccinia-related kinase 1, forming a new autoregulatory loop. | 1.80e-05 | 2 | 148 | 2 | 16782868 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 8898078 | ||
| Pubmed | Toll-like receptor 4-induced IL-22 accelerates kidney regeneration. | 1.80e-05 | 2 | 148 | 2 | 24459235 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 17118968 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 14550562 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 22665523 | ||
| Pubmed | p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction. | 1.80e-05 | 2 | 148 | 2 | 8617246 | |
| Pubmed | VRK1 interacts with p53 forming a basal complex that is activated by UV-induced DNA damage. | 1.80e-05 | 2 | 148 | 2 | 24492002 | |
| Interaction | EFTUD2 interactions | FLNB MYH10 TBRG4 ERCC5 EMC1 CCT3 LONP2 MTHFD1L UBR4 RBM42 DIDO1 PATL1 TFG CIT GSR PWP1 LUC7L NCAPG SF3B1 RUVBL1 DCD TSR1 CEBPZ TK1 DLAT SCAF11 MTCL1 TRMT1L DOT1L MED13 DYNC1I2 TP53 LRRFIP1 | 3.31e-09 | 1449 | 147 | 33 | int:EFTUD2 |
| Interaction | CIT interactions | RAD51 FLNB VRK1 HIP1 MYH10 CCT3 CFL2 UBR4 RBM42 DIDO1 DAPK3 CTIF RBM28 CIT HNRNPCL3 BICD1 PWP1 NBAS LUC7L LIG3 SF3B1 RUVBL1 NF2 DCD TSR1 CEBPZ HNRNPCL4 SCAF11 PRR14L OXSR1 TRMT1L PATJ TP53 | 3.37e-09 | 1450 | 147 | 33 | int:CIT |
| Interaction | PRMT1 interactions | FLNB MYH10 CCT3 MTHFD1L UBR4 ETFB RBM28 RB1CC1 TFG PDIA4 PWP1 NCAPG SF3B1 RUVBL1 RNH1 DCD TK1 DLAT SCAF11 FGD5 TP53 CA2 LRRFIP1 | 2.69e-07 | 929 | 147 | 23 | int:PRMT1 |
| Interaction | ACE2 interactions | FLNB MYH10 CCT3 MTHFD1L PDPK1 UBR4 RTTN ETFB RBM42 RBM28 CIT PDIA4 LIG3 NCAPG SF3B1 RUVBL1 RNH1 NF2 DCD SBDS GCC2 DLAT TRMT1L TP53 RAD54L | 4.21e-07 | 1106 | 147 | 25 | int:ACE2 |
| Interaction | SERBP1 interactions | FLNB CAAP1 VRK1 HIP1 TBRG4 CCT3 GLRX3 ETFB RBM42 DIDO1 CIT PDIA4 PWP1 NCAPG SF3B1 ADSS2 RNH1 UPF2 NF2 TSR1 SBDS DLAT OXSR1 DOT1L MAP2K1 DYNC1I2 TP53 ZNF292 | 1.42e-06 | 1432 | 147 | 28 | int:SERBP1 |
| Interaction | CAPZB interactions | FLNB HIP1 MYH10 CCT3 MTHFD1L CFL2 DAPK3 TFG COPS2 CIT BICD1 RUVBL1 TSR1 TBCK DLAT FGD5 MTCL1 PATJ PLEKHO1 DYNC1I2 TP53 RAI1 LRRFIP1 | 2.18e-06 | 1049 | 147 | 23 | int:CAPZB |
| Interaction | IFI16 interactions | RBM28 TFG CIT HNRNPCL3 PDIA4 PWP1 LUC7L LIG3 SF3B1 RNH1 SNX6 TSR1 CEBPZ DLAT TRMT1L DOT1L TP53 LRRFIP1 | 4.72e-06 | 714 | 147 | 18 | int:IFI16 |
| Interaction | OGT interactions | CAAP1 VRK1 UBE2Q1 CCT3 PKP4 RBM42 DIDO1 DAPK3 TFG COPS2 NXN CLCC1 BICD1 PWP1 RUVBL1 RNH1 ZSCAN21 SNX6 OXSR1 PLEKHO1 TP53 | 5.60e-06 | 950 | 147 | 21 | int:OGT |
| Interaction | TOP3B interactions | RAD51 MON2 SYNRG SEMA4B HIP1 MYH10 GLRX3 MTHFD1L UBR4 RTTN CTIF PATL1 MAPKAPK5 CIT LIG3 KMT2D UPF2 NF2 TMCC2 DLAT DOT1L SNAPC4 MED13 ELL TP53 RAI1 BAHCC1 | 7.26e-06 | 1470 | 147 | 27 | int:TOP3B |
| Interaction | NR2C2 interactions | CAAP1 VRK1 MYH10 TBRG4 CCT3 MTHFD1L UBR4 ETFB DIDO1 PATL1 RBM28 PWP1 LUC7L NCAPG SF3B1 RUVBL1 RNH1 UPF2 TSR1 CEBPZ TK1 OXSR1 TRMT1L DOT1L MAP2K1 CA2 | 9.44e-06 | 1403 | 147 | 26 | int:NR2C2 |
| Interaction | MYH9 interactions | FLNB HIP1 MYH10 MTHFD1L CFL2 DAPK3 COPS2 CIT BCAP31 NCAPG RUVBL1 RNH1 TSR1 FGD5 DOT1L DYNC1I2 TP53 LRRFIP1 | 9.95e-06 | 754 | 147 | 18 | int:MYH9 |
| Interaction | RPL13 interactions | VRK1 RBM42 RBM28 TUBGCP4 RB1CC1 MAPKAPK5 CIT LUC7L RPIA SF3B1 UPF2 NF2 CEBPZ TK1 SBDS TP53 RAI1 | 1.43e-05 | 700 | 147 | 17 | int:RPL13 |
| Interaction | TUBA1B interactions | RAD51 CCT3 COPS2 PDIA4 NCAPG SF3B1 RUVBL1 DCD TSR1 GCC2 CCT6B FGD5 MTCL1 LRRFIP1 | 1.75e-05 | 498 | 147 | 14 | int:TUBA1B |
| Interaction | RBM25 interactions | VRK1 MYH10 RBM28 CIT LUC7L NCAPG SF3B1 UPF2 OXSR1 DOT1L MAP2K1 | 2.58e-05 | 323 | 147 | 11 | int:RBM25 |
| Interaction | SUMO2 interactions | RAD51 FLNB CCT3 UBR4 DIDO1 PDIA4 NCAPG SF3B1 RUVBL1 DCD TSR1 TK1 SCAF11 TRMT1L TP53 | 2.85e-05 | 591 | 147 | 15 | int:SUMO2 |
| Interaction | DPP4 interactions | MYH10 EMC1 MTHFD1L CFL2 UBR4 RBM28 CLCC1 PDIA4 PWP1 NF2 GCC2 DLAT TP53 | 2.86e-05 | 453 | 147 | 13 | int:DPP4 |
| Interaction | SIRT7 interactions | FLNB MYH10 CCT3 MTHFD1L UBR4 DIDO1 RBM28 PDIA4 PWP1 SF3B1 RNH1 TSR1 CEBPZ DLAT SCAF11 TP53 RAI1 | 3.11e-05 | 744 | 147 | 17 | int:SIRT7 |
| Interaction | H3C1 interactions | VRK1 MYH10 UBR4 DIDO1 RBM28 COPS2 PWP1 LUC7L LIG3 FBLN1 KMT2D SF3B1 ADSS2 ZSCAN21 TSR1 GCC2 CCT6B PRR14L ZNF292 | 3.12e-05 | 901 | 147 | 19 | int:H3C1 |
| Interaction | HECTD1 interactions | RAD51 MYH10 CENPE PDK3 DIDO1 RBM28 PWP1 LIG3 NCAPG RUVBL1 UPF2 NF2 TSR1 CEBPZ CCT6B DLAT SCAF11 TRMT1L TP53 LRRFIP1 | 3.20e-05 | 984 | 147 | 20 | int:HECTD1 |
| Interaction | NEDD1 interactions | 3.62e-05 | 221 | 147 | 9 | int:NEDD1 | |
| Interaction | POLD1 interactions | 3.80e-05 | 337 | 147 | 11 | int:POLD1 | |
| Interaction | ACACA interactions | RAD51 MYH10 CCT3 DAPK3 PATL1 CLCC1 BICD1 NCAPG RNH1 SBDS OXSR1 ELL TP53 | 3.91e-05 | 467 | 147 | 13 | int:ACACA |
| Interaction | CUL4A interactions | MYH10 PDK3 CFL2 UBR4 TFG COPS2 PWP1 KRT76 RUVBL1 NF2 WDR11 TLR4 SCAF11 PRR14L OXSR1 DYNC1I2 TP53 CA2 | 5.15e-05 | 854 | 147 | 18 | int:CUL4A |
| Interaction | HSPD1 interactions | VRK1 TBRG4 PDK3 MTHFD1L CNTRL UBR4 ETFB MAPKAPK5 CIT RYR3 GSR SF3B1 ADSS2 TMCC2 MED12L DLAT FGD5 TRMT1L CA2 ZNF292 | 5.43e-05 | 1022 | 147 | 20 | int:HSPD1 |
| Interaction | RPL14 interactions | VRK1 RBM42 RBM28 TUBGCP4 RB1CC1 CIT LUC7L NF2 SNX6 CEBPZ SBDS SCAF11 TET3 TP53 | 5.59e-05 | 554 | 147 | 14 | int:RPL14 |
| Interaction | CLIP2 interactions | 5.60e-05 | 29 | 147 | 4 | int:CLIP2 | |
| Interaction | PSMC5 interactions | MYH10 EMC1 UBE2Q1 UBR4 RB1CC1 COPS2 CIT NCAPG RNH1 GCC2 PLEKHO1 DYNC1I2 TP53 | 5.63e-05 | 484 | 147 | 13 | int:PSMC5 |
| Interaction | IFITM1 interactions | 6.08e-05 | 355 | 147 | 11 | int:IFITM1 | |
| Interaction | DCTN2 interactions | FLNB MYH10 KIF3A BICD1 PDIA4 NCAPG RUVBL1 GCC2 TRMT1L DYNC1I2 TP53 | 6.23e-05 | 356 | 147 | 11 | int:DCTN2 |
| Interaction | ATG12 interactions | 6.49e-05 | 296 | 147 | 10 | int:ATG12 | |
| Interaction | FBXW7 interactions | RAD51 MYH10 CCT3 UBR4 DIDO1 CTIF RBM28 PWP1 LUC7L KMT2D NCAPG SF3B1 ADSS2 RUVBL1 TSR1 CEBPZ NFXL1 SCAF11 MTCL1 MAP2K1 MED13 TP53 | 7.08e-05 | 1215 | 147 | 22 | int:FBXW7 |
| Interaction | RPL3 interactions | VRK1 RBM42 RBM28 TUBGCP4 RB1CC1 CIT SF3B1 STXBP3 NF2 CEBPZ SBDS TRMT1L DOT1L PLEKHO1 TP53 RAI1 | 7.74e-05 | 722 | 147 | 16 | int:RPL3 |
| Interaction | BAP1 interactions | FLNB MYH10 CCT3 GLRX3 CFL2 UBR4 DIDO1 RB1CC1 TFG COPS2 GSR PDIA4 LIG3 SF3B1 RUVBL1 SNX6 TSR1 ALDH1L2 DLAT TRMT1L PATJ DYNC1I2 TP53 | 7.96e-05 | 1314 | 147 | 23 | int:BAP1 |
| Interaction | RBBP4 interactions | MYH10 COPS2 CIT NCAPG RUVBL1 NF2 DCD TK1 DOT1L DYNC1I2 TP53 RAI1 LRRFIP1 BAHCC1 | 8.01e-05 | 573 | 147 | 14 | int:RBBP4 |
| Interaction | PPP4C interactions | 8.33e-05 | 142 | 147 | 7 | int:PPP4C | |
| Interaction | RBBP7 interactions | CENPE COPS2 CIT BCAP31 NCAPG ADSS2 RUVBL1 DCD DOT1L DYNC1I2 TP53 LRRFIP1 BAHCC1 | 8.99e-05 | 507 | 147 | 13 | int:RBBP7 |
| Interaction | FASN interactions | MON2 FLNB VRK1 EMC1 UBR4 MAPKAPK5 CIT CLCC1 KIF3A GSR HNRNPCL3 NBAS NF2 SBDS CCT6B FGD5 DOT1L MED13 TP53 ZNF292 | 9.19e-05 | 1062 | 147 | 20 | int:FASN |
| Interaction | CHEK2 interactions | 9.38e-05 | 250 | 147 | 9 | int:CHEK2 | |
| Interaction | CAVIN2 interactions | 9.65e-05 | 63 | 147 | 5 | int:CAVIN2 | |
| Interaction | WDR83 interactions | 9.76e-05 | 196 | 147 | 8 | int:WDR83 | |
| Interaction | CENPA interactions | VRK1 ERCC5 LIG3 RUVBL1 ZSCAN21 TSR1 CEBPZ DOT1L TP53 RAI1 ZNF292 | 1.04e-04 | 377 | 147 | 11 | int:CENPA |
| Interaction | ATG16L1 interactions | MON2 CAAP1 VRK1 HIP1 CCT3 CNTRL BBS2 DTX3L RB1CC1 RYR2 KIF3A PWP1 NBAS RUVBL1 SBDS GCC2 CCT6B OXSR1 MTCL1 SNAPC4 PATJ | 1.07e-04 | 1161 | 147 | 21 | int:ATG16L1 |
| Interaction | FGB interactions | 1.08e-04 | 199 | 147 | 8 | int:FGB | |
| Interaction | RPL18A interactions | VRK1 RBM42 DIDO1 RBM28 TUBGCP4 CIT SF3B1 NF2 CEBPZ TRMT1L DOT1L TP53 | 1.10e-04 | 447 | 147 | 12 | int:RPL18A |
| Interaction | IQGAP1 interactions | FLNB MYH10 CCT3 CFL2 PDPK1 DAPK3 CIT NCAPG RUVBL1 FGD5 MAP2K1 DYNC1I2 TP53 LRRFIP1 | 1.11e-04 | 591 | 147 | 14 | int:IQGAP1 |
| Interaction | TUBB2A interactions | 1.11e-04 | 316 | 147 | 10 | int:TUBB2A | |
| Interaction | H3-3A interactions | VRK1 DIDO1 COPS2 LIG3 KMT2D SF3B1 RUVBL1 ZSCAN21 SNX6 TSR1 SCAF11 DOT1L SNAPC4 RAI1 LRRFIP1 ZNF292 | 1.18e-04 | 749 | 147 | 16 | int:H3-3A |
| Interaction | HOOK3 interactions | 1.20e-04 | 202 | 147 | 8 | int:HOOK3 | |
| Interaction | PPP1R12A interactions | 1.30e-04 | 322 | 147 | 10 | int:PPP1R12A | |
| Interaction | PSMD14 interactions | FLNB UBE2Q1 CCT3 CENPE GLRX3 CNTRL UBR4 STXBP3 RNH1 DCD PATJ MAP2K1 DYNC1I2 | 1.32e-04 | 527 | 147 | 13 | int:PSMD14 |
| Interaction | RPL31 interactions | RAD51 VRK1 ERCC5 RBM42 RBM28 CIT LUC7L LIG3 SF3B1 ADSS2 ZSCAN21 TSR1 CEBPZ TRMT1L TP53 | 1.38e-04 | 680 | 147 | 15 | int:RPL31 |
| Interaction | GRWD1 interactions | CCT3 UBR4 RBM28 CIT LUC7L KMT2D SF3B1 RUVBL1 ALDH1L2 DOT1L TP53 | 1.40e-04 | 390 | 147 | 11 | int:GRWD1 |
| Interaction | NUPR1 interactions | FLNB VRK1 HIP1 MYH10 CFL2 DAPK3 CIT PWP1 LIG3 SF3B1 RUVBL1 RNH1 NF2 TP53 LRRFIP1 | 1.44e-04 | 683 | 147 | 15 | int:NUPR1 |
| Interaction | TUBG2 interactions | 1.49e-04 | 37 | 147 | 4 | int:TUBG2 | |
| Interaction | MAPK8IP3 interactions | 1.59e-04 | 70 | 147 | 5 | int:MAPK8IP3 | |
| Interaction | HDAC1 interactions | RAD51 FLNB MYH10 CCT3 UBR4 RB1CC1 CIT KMT2D NCAPG RUVBL1 NF2 TSR1 GCC2 CCT6B DOT1L ELL TP53 RAI1 LRRFIP1 BAHCC1 | 1.63e-04 | 1108 | 147 | 20 | int:HDAC1 |
| Interaction | NPM1 interactions | FLNB VRK1 MYH10 MTHFD1L RBM42 DIDO1 RBM28 COPS2 CIT BICD1 PWP1 LUC7L NCAPG RNH1 TSR1 CEBPZ SBDS TRMT1L DOT1L DYNC1I2 TP53 | 1.71e-04 | 1201 | 147 | 21 | int:NPM1 |
| Interaction | PRPF4 interactions | 1.72e-04 | 271 | 147 | 9 | int:PRPF4 | |
| Interaction | DDX18 interactions | 1.75e-04 | 334 | 147 | 10 | int:DDX18 | |
| Interaction | MYH4 interactions | 1.94e-04 | 73 | 147 | 5 | int:MYH4 | |
| Interaction | NUP43 interactions | RAD51 ERCC5 CCT3 RBM28 CIT RYR2 LIG3 KMT2D RUVBL1 CEBPZ CCT6B TRMT1L TP53 ZNF292 | 1.98e-04 | 625 | 147 | 14 | int:NUP43 |
| Interaction | SRPK1 interactions | PDPK1 RBM42 RBM28 MAPKAPK5 CIT PWP1 LUC7L CEBPZ SCAF11 DOT1L MAP2K1 TP53 | 2.01e-04 | 477 | 147 | 12 | int:SRPK1 |
| Interaction | SMC4 interactions | 2.26e-04 | 281 | 147 | 9 | int:SMC4 | |
| Interaction | WHAMMP3 interactions | 2.40e-04 | 119 | 147 | 6 | int:WHAMMP3 | |
| Interaction | NCL interactions | RAD51 FLNB VRK1 MYH10 UBR4 RBM42 DIDO1 CIT RYR2 PWP1 TSR1 SBDS ABCC12 FGD5 DOT1L TP53 | 2.43e-04 | 798 | 147 | 16 | int:NCL |
| Interaction | TMPRSS11B interactions | MON2 EMC1 CAMLG UBR4 CLCC1 PDIA4 NBAS BCAP31 NFXL1 DLAT TP53 | 2.44e-04 | 416 | 147 | 11 | int:TMPRSS11B |
| Interaction | RPS19 interactions | RAD51 VRK1 UBR4 RBM42 RBM28 TUBGCP4 CIT HNRNPCL3 LUC7L SF3B1 TSR1 CEBPZ SCAF11 TP53 | 2.48e-04 | 639 | 147 | 14 | int:RPS19 |
| Interaction | DBN1 interactions | FLNB CFL2 RB1CC1 CIT NF2 TBCK FGD5 DOT1L DYNC1I2 TP53 LRRFIP1 | 2.49e-04 | 417 | 147 | 11 | int:DBN1 |
| Interaction | GGA1 interactions | 2.62e-04 | 121 | 147 | 6 | int:GGA1 | |
| Interaction | CLEC4E interactions | 2.72e-04 | 353 | 147 | 10 | int:CLEC4E | |
| Interaction | HSPA13 interactions | 2.74e-04 | 122 | 147 | 6 | int:HSPA13 | |
| Interaction | VCP interactions | MON2 FLNB CAAP1 EMC1 CCT3 GLRX3 PDK3 UBR4 RB1CC1 RYR3 GSR BCAP31 NCAPG ADSS2 RUVBL1 RNH1 TSR1 FGD5 DOT1L MAP2K1 DYNC1I2 TP53 LRRFIP1 | 2.90e-04 | 1435 | 147 | 23 | int:VCP |
| Interaction | RPL21 interactions | 2.98e-04 | 357 | 147 | 10 | int:RPL21 | |
| Interaction | TBKBP1 interactions | 2.99e-04 | 80 | 147 | 5 | int:TBKBP1 | |
| Interaction | C1orf127 interactions | 3.14e-04 | 4 | 147 | 2 | int:C1orf127 | |
| Interaction | RPS3A interactions | VRK1 MYH10 RBM42 RBM28 TUBGCP4 RB1CC1 COPS2 CIT RUVBL1 NF2 TSR1 FGD5 TP53 LRRFIP1 | 3.19e-04 | 655 | 147 | 14 | int:RPS3A |
| Interaction | DYNC1I2 interactions | 3.23e-04 | 295 | 147 | 9 | int:DYNC1I2 | |
| Interaction | LMO7 interactions | 3.25e-04 | 177 | 147 | 7 | int:LMO7 | |
| Interaction | HERC2 interactions | MYH10 UBR4 RB1CC1 MAPKAPK5 BICD1 LUC7L KMT2D SNX6 GCC2 PRR14L TP53 RAI1 | 3.26e-04 | 503 | 147 | 12 | int:HERC2 |
| Interaction | SOX7 interactions | 3.35e-04 | 82 | 147 | 5 | int:SOX7 | |
| Interaction | FOXP3 interactions | RAD51 RBM28 LUC7L LIG3 NCAPG TSR1 CEBPZ SCAF11 TRMT1L MAP2K1 TP53 | 3.36e-04 | 432 | 147 | 11 | int:FOXP3 |
| Interaction | CAPZA1 interactions | 3.63e-04 | 366 | 147 | 10 | int:CAPZA1 | |
| Interaction | PLEKHO1 interactions | 3.75e-04 | 84 | 147 | 5 | int:PLEKHO1 | |
| Interaction | CTSL interactions | 3.87e-04 | 240 | 147 | 8 | int:CTSL | |
| Interaction | STIP1 interactions | FLNB MYH10 CCT3 PDK3 UBR4 LIG3 BCAP31 NCAPG SF3B1 ADSS2 RUVBL1 RNH1 SNX6 DCD DLAT TRMT1L DYNC1I2 TP53 | 3.93e-04 | 1006 | 147 | 18 | int:STIP1 |
| Interaction | DEFB125 interactions | 3.96e-04 | 20 | 147 | 3 | int:DEFB125 | |
| Interaction | HOXC5 interactions | 4.12e-04 | 48 | 147 | 4 | int:HOXC5 | |
| Interaction | THRAP3 interactions | RBM42 COPS2 CIT LUC7L SF3B1 ADSS2 UPF2 TBCK DOT1L TP53 LRRFIP1 | 4.16e-04 | 443 | 147 | 11 | int:THRAP3 |
| Interaction | WWP2 interactions | CCT3 LONP2 MTHFD1L RUSC1 DIDO1 RBM28 LUC7L SF3B1 RUVBL1 NF2 TSR1 TK1 CCT6B TRMT1L PATJ TP53 | 4.28e-04 | 840 | 147 | 16 | int:WWP2 |
| Interaction | CHD3 interactions | RAD51 MYH10 RBM28 CIT LUC7L LIG3 SF3B1 RUVBL1 DCD TSR1 CEBPZ SCAF11 DOT1L TP53 RAI1 | 4.33e-04 | 757 | 147 | 15 | int:CHD3 |
| Interaction | THOC3 interactions | 4.41e-04 | 87 | 147 | 5 | int:THOC3 | |
| Interaction | AURKB interactions | MYH10 CCT3 CNTRL UBR4 RBM28 TFG CIT KIF3A SF3B1 RUVBL1 TSR1 HNRNPCL4 TRMT1L SNAPC4 TP53 | 4.57e-04 | 761 | 147 | 15 | int:AURKB |
| Interaction | MYH15 interactions | 4.59e-04 | 21 | 147 | 3 | int:MYH15 | |
| Interaction | PNPLA1 interactions | 4.59e-04 | 21 | 147 | 3 | int:PNPLA1 | |
| Interaction | TTC38 interactions | 4.59e-04 | 21 | 147 | 3 | int:TTC38 | |
| Interaction | AGR2 interactions | FLNB MYH10 CCT3 GLRX3 CAMLG CNTRL UBR4 GBP3 TFG PDIA4 NBAS BCAP31 STXBP3 ADSS2 RUVBL1 DCD CA2 | 4.74e-04 | 934 | 147 | 17 | int:AGR2 |
| Interaction | POLR1C interactions | 4.74e-04 | 311 | 147 | 9 | int:POLR1C | |
| Interaction | WDR5B interactions | 4.82e-04 | 50 | 147 | 4 | int:WDR5B | |
| Interaction | DAPK3 interactions | 4.89e-04 | 89 | 147 | 5 | int:DAPK3 | |
| Interaction | COX4I1 interactions | MYH10 TBRG4 EMC1 UBE2Q1 MTHFD1L UBR4 ETFB PDIA4 BCAP31 TBCK DLAT | 4.92e-04 | 452 | 147 | 11 | int:COX4I1 |
| Cytoband | 17q22-q23 | 1.54e-04 | 6 | 148 | 2 | 17q22-q23 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 5.08e-05 | 3 | 75 | 2 | 287 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 4.68e-04 | 8 | 75 | 2 | 1122 | |
| GeneFamily | Chaperonins | 1.72e-03 | 15 | 75 | 2 | 587 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | VRK1 CCT3 CENPE CNTRL SQLE RB1CC1 MAPKAPK5 GSR PWP1 FBLN1 RPIA KRT76 RUVBL1 TSR1 CEBPZ DLAT OXSR1 RAD54L | 2.88e-07 | 761 | 147 | 18 | M11961 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | UBE2Q1 LONP2 PDPK1 UBR4 LENG1 RBM42 PATL1 PRPF18 PWP1 BCAP31 SF3B1 RUVBL1 TSR1 CEBPZ SBDS WDR45B OXSR1 MAP2K1 MED13 ELL | 5.33e-06 | 1129 | 147 | 20 | M42508 |
| Coexpression | MEBARKI_HCC_PROGENITOR_FZD8CRD_UP | RAD51 CRISPLD2 VRK1 CENPE MTHFD1L CIT LIG3 NCAPG NF2 TK1 MTCL1 FHDC1 PLEKHO1 RAD54L | 6.06e-06 | 588 | 147 | 14 | M38992 |
| Coexpression | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN | TBRG4 PDK3 TUBGCP4 MAPKAPK5 TFG PRPF18 PWP1 SF3B1 SNX6 PKIA CCT6B SCAF11 OXSR1 MAP2K1 | 6.30e-06 | 590 | 147 | 14 | M16066 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | FLNB VRK1 CENPE PKP4 CTIF RB1CC1 BICD1 NBAS STXBP3 UPF2 GCC2 OXSR1 MTCL1 MAP2K1 MED13 LRRFIP1 ZNF292 | 6.61e-06 | 856 | 147 | 17 | M4500 |
| Coexpression | HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP | 7.40e-06 | 177 | 147 | 8 | M6564 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | UBE2Q1 LONP2 PDPK1 UBR4 LENG1 RBM42 PATL1 PRPF18 PWP1 BCAP31 SF3B1 RUVBL1 TSR1 CEBPZ SBDS WDR45B OXSR1 MAP2K1 MED13 ELL | 7.75e-06 | 1158 | 147 | 20 | MM1338 |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_1_DN | 9.98e-06 | 378 | 147 | 11 | M17788 | |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_UP | 1.02e-05 | 185 | 147 | 8 | M374 | |
| Coexpression | LIAO_METASTASIS | CIB2 GLDN EMC1 MTHFD1L PKP4 PDIA4 CABYR FBLN1 MTCL1 CTNND2 SNAPC4 RAD54L ZNF292 | 1.18e-05 | 540 | 147 | 13 | M13809 |
| Coexpression | GSE360_L_MAJOR_VS_T_GONDII_DC_DN | 1.67e-05 | 198 | 147 | 8 | M5208 | |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN | VRK1 MYH10 CENPE PDK3 SQLE ETFB LUC7L BCAP31 NCAPG TSR1 TK1 PKIA DLAT RAD54L | 2.56e-05 | 669 | 147 | 14 | M18635 |
| Coexpression | REN_BOUND_BY_E2F | 2.59e-05 | 62 | 147 | 5 | M4493 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | RAD51 CRISPLD2 HIP1 CCT3 CENPE MTHFD1L PKP4 PATL1 RBM28 TUBGCP4 MAPKAPK5 COPS2 CLCC1 PWP1 NCAPG SF3B1 GBP5 TSR1 TK1 MTCL1 RAD54L | 3.98e-05 | 1407 | 147 | 21 | M14427 |
| Coexpression | MUELLER_PLURINET | 5.05e-05 | 299 | 147 | 9 | M123 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | RAD51 FLNB VRK1 CCT3 CFL2 PKP4 GSR TSR1 TK1 PKIA TP53 LRRFIP1 | 6.66e-05 | 550 | 147 | 12 | M16189 |
| Coexpression | GSE14415_NATURAL_TREG_VS_TCONV_DN | 7.27e-05 | 180 | 147 | 7 | M2961 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN | MON2 LRRC34 CCT3 TSPOAP1 CFL2 PKP4 SQLE RBM28 TUBGCP4 PWP1 LUC7L RPIA RUVBL1 TSR1 SCAF11 CA2 BAHCC1 | 8.21e-05 | 1045 | 147 | 17 | M8525 |
| Coexpression | KRIEG_HYPOXIA_NOT_VIA_KDM3A | RAD51 MYH10 ERCC5 MTHFD1L DAPK3 LUC7L TSR1 TK1 WDR45B OXSR1 MTCL1 MAP2K1 PLEKHO1 ZNF292 | 8.25e-05 | 746 | 147 | 14 | M2469 |
| Coexpression | VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_UP | 8.32e-05 | 127 | 147 | 6 | M40952 | |
| Coexpression | GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN | 8.93e-05 | 186 | 147 | 7 | M8175 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN | MON2 SEMA4B LRRC34 CCT3 TSPOAP1 CFL2 SQLE RBM28 TUBGCP4 PWP1 LUC7L RPIA RUVBL1 TSR1 CA2 BAHCC1 | 9.02e-05 | 950 | 147 | 16 | M19907 |
| Coexpression | BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN | 9.24e-05 | 187 | 147 | 7 | M34027 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 9.24e-05 | 187 | 147 | 7 | M2984 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | RAD51 FLNB VRK1 CCT3 CFL2 PKP4 GSR TSR1 TK1 PKIA TP53 LRRFIP1 | 9.49e-05 | 571 | 147 | 12 | MM1100 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | VRK1 ERCC5 CNTRL DIDO1 RB1CC1 PRPF18 CREBZF GSR FBLN1 RPIA SF3B1 STXBP3 RUVBL1 UPF2 CEBPZ SCAF11 OXSR1 TP53 RAD54L LRRFIP1 | 1.06e-04 | 1394 | 147 | 20 | M9585 |
| Coexpression | GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_DN | 1.28e-04 | 197 | 147 | 7 | M7696 | |
| Coexpression | GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_DN | 1.28e-04 | 197 | 147 | 7 | M7683 | |
| Coexpression | GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN | 1.32e-04 | 198 | 147 | 7 | M8628 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_TH2_DN | 1.32e-04 | 198 | 147 | 7 | M5425 | |
| Coexpression | GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP | 1.36e-04 | 199 | 147 | 7 | M7274 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_MAST_CELL_UP | 1.36e-04 | 199 | 147 | 7 | M5397 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP | 1.40e-04 | 200 | 147 | 7 | M4622 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_24H_BMDC_DN | 1.40e-04 | 200 | 147 | 7 | M3954 | |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_P6 | 1.81e-04 | 93 | 147 | 5 | M1735 | |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_P6 | 2.00e-04 | 95 | 147 | 5 | MM1217 | |
| Coexpression | HALLMARK_DNA_REPAIR | 2.07e-04 | 150 | 147 | 6 | M5898 | |
| Coexpression | HAY_BONE_MARROW_ERYTHROBLAST | VRK1 MYH10 TBRG4 CCT3 CENPE GLRX3 PKP4 ETFB CIT NBAS RPIA NCAPG RUVBL1 TSR1 TK1 FHDC1 RAD54L CA2 | 2.81e-04 | 1271 | 147 | 18 | M39197 |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.56e-08 | 190 | 148 | 9 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 2.02e-07 | 185 | 148 | 8 | 9d3168c7f0b1d739f78b368969cf5c77ce202b97 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.69e-07 | 192 | 148 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.80e-07 | 193 | 148 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.67e-07 | 200 | 148 | 8 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-06 | 177 | 148 | 7 | 1d5a071157c755f3a27a5c3143015da04ee0b0dc | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.34e-06 | 179 | 148 | 7 | e67ad7ab04d0c1309296f57c1f53c5ca14c213fe | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.91e-06 | 185 | 148 | 7 | 0e0f043ad6d2a62cd47ce39911ad81feab4a4d7e | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.91e-06 | 185 | 148 | 7 | 89b85ce8026dc80c1bd9f76dfe16401c173b7946 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 3.23e-06 | 188 | 148 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative|Multiple_Sclerosis / Disease, Lineage and Cell Type | 3.23e-06 | 188 | 148 | 7 | 6c05797a5d0635d89ffcf4aca52178687129ccb4 | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 3.23e-06 | 188 | 148 | 7 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.72e-06 | 192 | 148 | 7 | 5ef79faddb433c09ff36660d8bf7a3af5a67bf1d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.85e-06 | 193 | 148 | 7 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Polychromatic_Erythroblast|World / Lineage, cell class and subclass | 3.98e-06 | 194 | 148 | 7 | 008bb0072f414a48d052429101bdc990ee4f80c2 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.55e-06 | 198 | 148 | 7 | 880f9817f5145f10f29fc05c5866090433532fe2 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.55e-06 | 198 | 148 | 7 | 844f534551483c89ef789d1cfeb4680e54f794b2 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.55e-06 | 198 | 148 | 7 | 8afeb1f9bc9d8551482c8fefe4c5f88d9cd13ee2 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Ccnb1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.67e-06 | 129 | 148 | 6 | ff74d159034a09f7b174da18bfb9a26936252b4c | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 4.70e-06 | 199 | 148 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.86e-06 | 200 | 148 | 7 | 3835a8a9739b8cd5bf19c40765ef76907ac1ad38 | |
| ToppCell | distal-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.86e-06 | 200 | 148 | 7 | 0cd3b01fb7f579e5abf000adb8ec8adc7cd779c4 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors_nGenesUnder4k|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.86e-06 | 200 | 148 | 7 | 8223d2c9b9e05b1d26e3de1bc0226d175af2e7b2 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-T/NK_proliferative|IIF / Disease, condition lineage and cell class | 4.86e-06 | 200 | 148 | 7 | c7c1806a1054b2b034a26a18aac93fc3bec4dbc8 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 4.86e-06 | 200 | 148 | 7 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.33e-06 | 132 | 148 | 6 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-05 | 157 | 148 | 6 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 166 | 148 | 6 | 21ba5fd755c0fb31ada42a1b5d60bede0153323d | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-CD45____B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 170 | 148 | 6 | 6210ee3bf29059e6149c047bb7e02c5f59441519 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.65e-05 | 175 | 148 | 6 | 74800a10f5ff25d5414fbccb0668f92ff077d1cc | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-05 | 177 | 148 | 6 | 8a0f0fbb06cdacb99a3fdba0da3e0494b891db4f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.83e-05 | 177 | 148 | 6 | e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.83e-05 | 177 | 148 | 6 | 844017225e9039d1bc621a9630a30c2e9a51b36d | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.83e-05 | 177 | 148 | 6 | 43ba6f12c2fb32698a420bf799d46ac1b558f146 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.83e-05 | 177 | 148 | 6 | 26c25d10aa511b64cc7db43a8deea7b5d31bca96 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-05 | 177 | 148 | 6 | e9d7682517fb30fd2ad535d59779d718a7024c13 | |
| ToppCell | NS-moderate-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.83e-05 | 177 | 148 | 6 | 174c54acfe19e2bb31418d69e228032ba724cbb6 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.83e-05 | 177 | 148 | 6 | d2c1f46913ac00bbc0bb9320d5652edc01b34179 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.83e-05 | 177 | 148 | 6 | 65e090aad0ffb737ce034e25bd5b12a0b1dd9684 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.01e-05 | 179 | 148 | 6 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.01e-05 | 179 | 148 | 6 | df4d0b2fe47d2c7def729b3217cb01ced01495ff | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.20e-05 | 181 | 148 | 6 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.20e-05 | 181 | 148 | 6 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.20e-05 | 181 | 148 | 6 | cf13bf7a531a2d40f8d778629cf2431b684f65f3 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.20e-05 | 181 | 148 | 6 | 74311aac2fe27dc02a9be3bc20e0c7ef1c239049 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.20e-05 | 181 | 148 | 6 | be4f35c9eb5b3083acb2264128f095fac1f3da45 | |
| ToppCell | HSPCs-Mono_prog.|World / Lineage and Cell class | 3.41e-05 | 183 | 148 | 6 | 1b73070baa9e5d5ada4ce25a77741630af9c1a3a | |
| ToppCell | IIF-Lymphocyte-T_NK-T_NK_proliferative|IIF / Disease, Lineage and Cell Type | 3.51e-05 | 184 | 148 | 6 | ab8b45ce40e8c5f66e5c23332a591b4f9cba4ce1 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-T_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 184 | 148 | 6 | 185b49630da61cbf45c0926d1b992943296d2a54 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.51e-05 | 184 | 148 | 6 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | URO-Lymphocyte-T_NK-T_NK_proliferative|URO / Disease, Lineage and Cell Type | 3.62e-05 | 185 | 148 | 6 | 0ae9c646679c69a553eda670aef0e0495feb0286 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.62e-05 | 185 | 148 | 6 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-05 | 186 | 148 | 6 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-05 | 186 | 148 | 6 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-05 | 187 | 148 | 6 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | 3.96e-05 | 188 | 148 | 6 | be3db9768364568f44e32ae6b3bf99e49b0978bb | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.96e-05 | 188 | 148 | 6 | 95d0a796d62ce6d121e2028c378faffc14b35275 | |
| ToppCell | normal-na-Lymphocytic|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.08e-05 | 189 | 148 | 6 | 1d382f8eb998c6a30e09fddc9a427afc8f5f7323 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-05 | 189 | 148 | 6 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | normal-na-Lymphocytic-lymphocyte|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.08e-05 | 189 | 148 | 6 | b83fd81ecc5ef363be7435ee12cb7079e2434af7 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.08e-05 | 189 | 148 | 6 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | normal-na-Lymphocytic-lymphocyte-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.08e-05 | 189 | 148 | 6 | 3db4177d68cab4cd16842d2ebcaca28f69300e44 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.20e-05 | 190 | 148 | 6 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.32e-05 | 191 | 148 | 6 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.32e-05 | 191 | 148 | 6 | 2b056cbe2e82e056e1f798974999378460eb1d16 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.32e-05 | 191 | 148 | 6 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.32e-05 | 191 | 148 | 6 | b978afe76754cc56e1672abca27be289bb56375b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.45e-05 | 192 | 148 | 6 | 69758a256386a6ed3a6e2c94c55d59baa34892d7 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.45e-05 | 192 | 148 | 6 | 4e689bca7a242f8482e25f273656e2caba8821c0 | |
| ToppCell | Proliferating|World / shred by cell class for mouse tongue | 4.45e-05 | 192 | 148 | 6 | f081f3f957cc782294e118fcc1055f6a4264ee98 | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.45e-05 | 192 | 148 | 6 | 0445fdc670fa7b847dcd0a061d7736ddcf3519ba | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 193 | 148 | 6 | 40eedc1490c113403bc7c12a6bdf976f4f8bca84 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.58e-05 | 193 | 148 | 6 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.58e-05 | 193 | 148 | 6 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.58e-05 | 193 | 148 | 6 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.58e-05 | 193 | 148 | 6 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.58e-05 | 193 | 148 | 6 | 947200ef6c3a2e35ad7e6b4af29d92384bdf73f5 | |
| ToppCell | control-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.58e-05 | 193 | 148 | 6 | ecb4018a47d9a82bb999e0bc8b3dceabd97d1f0d | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-05 | 194 | 148 | 6 | 2cac1b9c4da01faaec9a67ec06f47a7060760225 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.72e-05 | 194 | 148 | 6 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 4.72e-05 | 194 | 148 | 6 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | Control-Lymphocyte-T_NK-T_NK_proliferative|Control / Disease, Lineage and Cell Type | 4.72e-05 | 194 | 148 | 6 | 844731b7943d1cfca819b7b89e4e62067bfa0230 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.72e-05 | 194 | 148 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.72e-05 | 194 | 148 | 6 | af4bbb2deb5a3913eb58990690fc3c62fbc3708c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.72e-05 | 194 | 148 | 6 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.72e-05 | 194 | 148 | 6 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.72e-05 | 194 | 148 | 6 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.72e-05 | 194 | 148 | 6 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.85e-05 | 195 | 148 | 6 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.85e-05 | 195 | 148 | 6 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.85e-05 | 195 | 148 | 6 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.85e-05 | 195 | 148 | 6 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.85e-05 | 195 | 148 | 6 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 195 | 148 | 6 | b57132802cb977551e214880984f3edcd375474f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.85e-05 | 195 | 148 | 6 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.85e-05 | 195 | 148 | 6 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.99e-05 | 196 | 148 | 6 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 4.99e-05 | 196 | 148 | 6 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.99e-05 | 196 | 148 | 6 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.99e-05 | 196 | 148 | 6 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| Drug | Retinoic acid [302-79-4]; Down 200; 13.4uM; HL60; HG-U133A | 3.75e-07 | 186 | 147 | 10 | 1548_DN | |
| Disease | Intellectual Disability | VRK1 RTTN RBM28 TFG MED12L WDR45B TET3 MED13 DYNC1I2 RAI1 CA2 ZNF292 | 2.00e-06 | 447 | 143 | 12 | C3714756 |
| Disease | BREAST CANCER | 2.97e-06 | 21 | 143 | 4 | 114480 | |
| Disease | Malignant tumor of breast | 8.51e-06 | 27 | 143 | 4 | cv:C0006142 | |
| Disease | Breast neoplasm | 8.51e-06 | 27 | 143 | 4 | cv:C1458155 | |
| Disease | Familial cancer of breast | 8.51e-06 | 27 | 143 | 4 | cv:C0346153 | |
| Disease | Clumsiness - motor delay | 2.33e-05 | 2 | 143 | 2 | C0520947 | |
| Disease | Malignant neoplasm of breast | RAD51 FLNB SYT3 CFL2 PDPK1 UBR4 CTIF DTX3L RB1CC1 KMT2D KRT76 NF2 FGD5 TP53 RAD54L LRRFIP1 | 6.85e-05 | 1074 | 143 | 16 | C0006142 |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 6.97e-05 | 3 | 143 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 6.97e-05 | 3 | 143 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Motor delay | 6.97e-05 | 3 | 143 | 2 | C1854301 | |
| Disease | Growth abnormality | 6.97e-05 | 3 | 143 | 2 | C0262361 | |
| Disease | melanoma | 2.16e-04 | 248 | 143 | 7 | C0025202 | |
| Disease | Delayed speech and language development | 2.31e-04 | 5 | 143 | 2 | C0454644 | |
| Disease | aortic measurement | 2.32e-04 | 251 | 143 | 7 | EFO_0020865 | |
| Disease | MYELODYSPLASTIC SYNDROME | 3.20e-04 | 67 | 143 | 4 | C3463824 | |
| Disease | melanoma (is_implicated_in) | 5.97e-04 | 34 | 143 | 3 | DOID:1909 (is_implicated_in) | |
| Disease | low tension glaucoma (is_implicated_in) | 6.41e-04 | 8 | 143 | 2 | DOID:13544 (is_implicated_in) | |
| Disease | Leigh syndrome | 6.41e-04 | 8 | 143 | 2 | cv:C0023264 | |
| Disease | Autistic behavior | 6.41e-04 | 8 | 143 | 2 | C0856975 | |
| Disease | Colorectal Carcinoma | MTHFD1L TFG NXN LIG3 CABYR NCAPG TK1 TLR4 CTNND2 TP53 ZNF292 | 6.47e-04 | 702 | 143 | 11 | C0009402 |
| Disease | Seizures | 7.00e-04 | 218 | 143 | 6 | C0036572 | |
| Disease | Hereditary hearing loss and deafness | 7.44e-04 | 146 | 143 | 5 | cv:C0236038 | |
| Disease | Autism Spectrum Disorders | 7.90e-04 | 85 | 143 | 4 | C1510586 | |
| Disease | Abnormality of the face | 8.21e-04 | 9 | 143 | 2 | C4025871 | |
| Disease | breast cancer (is_implicated_in) | 8.40e-04 | 150 | 143 | 5 | DOID:1612 (is_implicated_in) | |
| Disease | Abnormality of nervous system morphology | 1.02e-03 | 10 | 143 | 2 | C4022810 | |
| Disease | Cutaneous Melanoma | 1.04e-03 | 41 | 143 | 3 | C0151779 | |
| Disease | Squamous cell carcinoma of esophagus | 1.20e-03 | 95 | 143 | 4 | C0279626 | |
| Disease | Adenocarcinoma of large intestine | 1.24e-03 | 96 | 143 | 4 | C1319315 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 1.25e-03 | 11 | 143 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | Bardet-Biedl syndrome (implicated_via_orthology) | 1.25e-03 | 11 | 143 | 2 | DOID:1935 (implicated_via_orthology) | |
| Disease | multiple sclerosis symptom measurement | 1.45e-03 | 46 | 143 | 3 | EFO_0803536 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 1.93e-03 | 181 | 143 | 5 | DOID:684 (is_implicated_in) | |
| Disease | Malignant mesothelioma | 1.98e-03 | 109 | 143 | 4 | C0345967 | |
| Disease | Bardet-Biedl syndrome (is_implicated_in) | 2.04e-03 | 14 | 143 | 2 | DOID:1935 (is_implicated_in) | |
| Disease | Adenocarcinoma Of Esophagus | 2.04e-03 | 14 | 143 | 2 | C0279628 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 2.04e-03 | 14 | 143 | 2 | C0677776 | |
| Disease | Colorectal Neoplasms | 2.37e-03 | 277 | 143 | 6 | C0009404 | |
| Disease | Polydactyly | 2.57e-03 | 117 | 143 | 4 | C0152427 | |
| Disease | cholesteatoma of middle ear (is_marker_for) | 2.68e-03 | 16 | 143 | 2 | DOID:10964 (is_marker_for) | |
| Disease | T-Cell Lymphoma | 2.68e-03 | 16 | 143 | 2 | C0079772 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 3.02e-03 | 17 | 143 | 2 | C2936862 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 3.02e-03 | 17 | 143 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | Bardet-Biedl syndrome | 3.39e-03 | 18 | 143 | 2 | cv:C0752166 | |
| Disease | Schizophrenia | PDYN RB1CC1 ADSS2 WDR11 PVALB TLR4 OXSR1 CTNND2 MDGA1 TP53 RAI1 | 3.91e-03 | 883 | 143 | 11 | C0036341 |
| Disease | smoking status measurement | MON2 CAAP1 TBRG4 SYT3 CTIF RYR2 TLR4 MED12L CTNND2 MDGA1 TET3 ELL DYNC1I2 | 4.30e-03 | 1160 | 143 | 13 | EFO_0006527 |
| Disease | Abdominal Aortic Aneurysm | 4.44e-03 | 68 | 143 | 3 | EFO_0004214 | |
| Disease | intrinsic cardiomyopathy (implicated_via_orthology) | 4.61e-03 | 21 | 143 | 2 | DOID:0060036 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ENAKALADSGGIEKL | 951 | Q99569 | |
| GVAEVKGTQLGDKLD | 101 | P49069 | |
| EQGGIGAEAKRKSLE | 556 | Q9P281 | |
| FSEELGLAIEKLKDG | 316 | Q8N3I7 | |
| ANEALKKDLEGVISG | 606 | Q7Z7A1 | |
| EAERGKGKTGEIAVD | 521 | Q8IUX8 | |
| KDGLTQADKDALDGL | 231 | P55199 | |
| ELKAELDGEKGRDSG | 386 | Q96G01 | |
| TDDGEDDLKKGTQLL | 181 | P61201 | |
| GKGKLEDGDGINLND | 146 | O43310 | |
| VKQSGFGKDLGEEAL | 896 | Q3SY69 | |
| DLSLNKLGIQTDDKG | 341 | P00390 | |
| KGDKGDVSNDVLLAG | 216 | Q6ZMI3 | |
| QLLDAEGAIKIGSEK | 401 | O75952 | |
| GLELKQGKGEDSDVL | 241 | Q9H8G2 | |
| GALQLAGEKSSEKGL | 836 | Q8TEK3 | |
| EKDVDGVTDINLGKL | 176 | Q6UB35 | |
| ENAKALRDAGGIEKL | 976 | Q9UQB3 | |
| AKLLGNSLLKLEGDD | 1576 | O14578 | |
| FTLLGAGGEEEEKKD | 286 | Q01814 | |
| NVDLEEAGKEGGKSR | 61 | Q9ULK2 | |
| GELKDDDFEKISELG | 61 | Q02750 | |
| TLLDGKLVLLGGEEE | 141 | Q86YV0 | |
| ILGLQEAIGEKADKA | 611 | Q7Z5J4 | |
| GKGEILASLQDGAAE | 26 | Q12829 | |
| GDSDVGKGEILESLQ | 21 | Q96S21 | |
| GKGEILESLQDGAAE | 26 | Q96S21 | |
| EAGGLKLDGRQLKVD | 401 | Q9NW13 | |
| ELGLGLGLGLKEKEE | 236 | Q9BTD8 | |
| KGSFVGDIAKDLGLE | 41 | Q9Y5G6 | |
| EGNQEAGKELKAGEL | 1111 | Q9H0J4 | |
| SKELDKLLQGGIETG | 106 | Q06609 | |
| LAIDGGSKDEIDQKL | 241 | Q92698 | |
| EGQILKVFGDKDADG | 1656 | O95153 | |
| EQLEEKTENKLGELG | 1186 | Q9Y4B5 | |
| KLAGLDINKTEGEED | 41 | P61925 | |
| DVKAGNILLGEDGSV | 146 | O95747 | |
| DSLLGERGNLEGELK | 246 | Q01546 | |
| LGDIAIDDVTLKKGE | 901 | Q8NFP4 | |
| GKLDGLIKETEENEN | 876 | Q8TDY2 | |
| ENDVELLTKKGAEGL | 501 | Q9C0D6 | |
| EKLSAAEEIQGDGPK | 441 | Q86TB9 | |
| SGKGKEEETLIQGRE | 106 | Q8NFK1 | |
| LQEVDEEIKKGLAAG | 76 | Q8IZ02 | |
| LDEVDKLGKSLQGDP | 441 | Q86WA8 | |
| QGRVLKAAGEELEKG | 1426 | Q86YW9 | |
| EEIGKLLAKAEQLGA | 131 | Q9NQ29 | |
| ILPQAGKGENEDEKL | 401 | Q8IW41 | |
| EGDEDFEGKQGKILA | 111 | Q6ZNB6 | |
| LVGGLDIVKELKENG | 311 | O76003 | |
| QLELIKDDEKGAEEG | 266 | B7ZW38 | |
| ELLEEGKGVIRGNKE | 81 | Q96BZ8 | |
| GKLDVGNAEVKLEEE | 166 | P51572 | |
| DLEDKEGEIQAGAKL | 251 | Q13409 | |
| DDIKDRSTLGEKLGG | 141 | Q9Y281 | |
| GLEELVKQKDFLDGV | 496 | O75369 | |
| DVEGEGLNLGISKEE | 1171 | Q9ULL4 | |
| KVGEKLSEGDLLAEI | 241 | P10515 | |
| LNDKEDLGSKSVGEG | 76 | P01213 | |
| LGKERVKGSLDQLDE | 631 | O95263 | |
| LDDKGGLVDITRNGK | 341 | Q9H0B8 | |
| DEPKDEGSVGNKALV | 76 | Q6ZNL6 | |
| QEEAKGALLGTSGLK | 396 | O43293 | |
| GKLGKDAVEDLESVG | 81 | P81605 | |
| LDTEGLGDVKKGDNQ | 96 | Q9H0R5 | |
| LDTEGLGDVEKADNK | 96 | Q96PP8 | |
| DEEDLGIGGLTGKQL | 221 | Q9UGJ1 | |
| QLELIKDDEKGAEEG | 266 | P0DMR1 | |
| EALELKDAQAGKEPG | 346 | P04637 | |
| ADKEKIESGGGNILI | 1086 | Q7Z3U7 | |
| QEGLEGLVLKDVKGT | 651 | P49916 | |
| VGGVDLLAKAEEQEK | 481 | Q9Y496 | |
| LGTEKEVEVIGGADK | 166 | P04183 | |
| DLEALLAIGKGADDG | 611 | A2RRP1 | |
| NKKGTELLLGVDALG | 226 | P35240 | |
| GDLDVGGLQETDKII | 151 | P23142 | |
| FDGDGKKELLVGSED | 171 | Q9BXC9 | |
| DVKAEPIDDGKGLNL | 111 | Q96DR5 | |
| EKGGELTLLGTQDDI | 336 | Q8TDB6 | |
| KDLGLGDTVEGLDAQ | 176 | Q14534 | |
| NELTGGLEETLKEKD | 646 | Q8IWJ2 | |
| KAAQDIKDEEPGDLG | 241 | Q9BTC0 | |
| QAELEGEFGKKADGL | 466 | Q8N766 | |
| LLAGEGKLSGRQKEE | 406 | P57679 | |
| KDIVDGKEKEGQELG | 241 | O75363 | |
| LEKGGDPLEKQDQIS | 516 | Q99590 | |
| KGSLEVLNLKDVEEG | 231 | Q9Y3A5 | |
| KELSVDDAKLQGAGE | 1866 | Q92736 | |
| VQGLLEEIGKTKDDL | 791 | Q02224 | |
| AKKEEELQGALARGD | 1086 | P35580 | |
| LDENEEVIDGGKKGA | 61 | Q03701 | |
| EVIDGGKKGAIDDLQ | 66 | Q03701 | |
| GKKGAIDDLQQGELE | 71 | Q03701 | |
| LQETLKGLLGSADKG | 496 | Q969Z0 | |
| LDEGVAKDNAKIDGA | 696 | Q32MZ4 | |
| ESLGLGKLGTQAEKD | 861 | O75334 | |
| IEEDGEGLLKAGSIA | 1336 | Q5VU65 | |
| IKLSEEGLEGKEQDV | 896 | Q5THK1 | |
| GGDEAEDLTKKLLDE | 536 | Q9HAU5 | |
| GADEVDADLNLIKGG | 161 | P49247 | |
| ELLEADDGKIDAGKT | 211 | Q9BVN2 | |
| FLSDIGKEGEKNLLE | 556 | Q86VV8 | |
| GKEGEKNLLELVELA | 561 | Q86VV8 | |
| DIVEGGSEKADLGEL | 421 | Q9BQG1 | |
| KSDDILEEGEKNLGN | 336 | Q7Z2T5 | |
| AGDIKLTKDGNVLLD | 51 | Q92526 | |
| ELEKAKAAQALEGGE | 481 | P35499 | |
| IGDKVDKGDLVALSL | 246 | O75069 | |
| LSLEGSGLGVEDLKD | 751 | Q9UMZ2 | |
| EELLGEKLVTGGGEE | 6 | Q6DKJ4 | |
| SEDEKRLLLEKQAGG | 431 | O15530 | |
| EGDKLKVEREIDGGL | 156 | P38117 | |
| ENSDEGLKVRDGKGI | 426 | P28715 | |
| GLDIKQEELGDLVDK | 771 | O00291 | |
| DEKGNVLLEDGKGRC | 171 | Q9NPR2 | |
| DDVGTGAGLLEIKKI | 341 | P49368 | |
| GEDVNAAILDESGKK | 471 | P13667 | |
| LKEKEKQEFLEGGVG | 41 | Q5MNZ6 | |
| EGKGKVVDLLAQDAD | 41 | P30520 | |
| GESGEIKAIGELDLL | 156 | Q9GZX6 | |
| GGLKESEKLSDDLIL | 1176 | Q9UHV7 | |
| DLALGTDAEGQKVKD | 371 | O00186 | |
| IVLAPGNEKDEGKES | 736 | Q96J65 | |
| LGKEDLSIKISDLGG | 276 | Q15120 | |
| ELLAEVQGLGDGKRK | 321 | Q53GL0 | |
| DDSQDKAVLKGGPLD | 71 | P00918 | |
| KVIEEADLDGDGKLG | 151 | O75838 | |
| LKSKGDEGEEFLEQI | 346 | Q9BPX3 | |
| IEAGKLGLPDENKGD | 106 | Q96S66 | |
| IAEAKEKLQEEGGGS | 36 | Q13610 | |
| KGEGELKNLELDEEV | 31 | A0JNW5 | |
| EAVLAEKRQLGGKDG | 66 | Q2NL82 | |
| EQKGSEAEGLKGDII | 211 | Q9Y5A6 | |
| DLSGKLIIKAQLGED | 6 | Q92734 | |
| ELEKDKNGLGLSLAG | 1241 | Q8NI35 | |
| LKADGKGDTQEAELL | 3236 | Q15413 | |
| KKAALDEAQGVGLDS | 21 | O75533 | |
| LDKDKSGFIEEDELG | 51 | P20472 | |
| VGANSGLLKDIGDEK | 501 | O60281 | |
| GKQKQDLLEEDDSAG | 311 | Q9NS37 | |
| LKELSLAGNELGDEG | 286 | P13489 | |
| LAGGDLEKELVNKEI | 331 | Q8TEA7 | |
| VGLLKEVEIKAGEGA | 96 | O43151 | |
| VKGLGLDESGLAKQA | 21 | Q9Y265 | |
| DASREKLQKLGEGEG | 101 | Q9UNH7 | |
| DGKLDLSVVENGGLK | 336 | Q99986 | |
| KGALDLGLLSQEGEA | 1266 | Q5SXM2 | |
| SKAGAAGKDLLNELE | 1201 | Q9BZH6 | |
| DGEDEKDKGALDNLL | 3011 | Q5T4S7 | |
| EGNLEKFDKSALEGL | 266 | O00206 | |
| IEELEALGESLGKGD | 166 | Q99633 | |
| KSEDDGIGKENLAIL | 216 | Q7Z7E8 | |
| KDGDLDTDELLKGEG | 1641 | O14686 |